WallStreetZenWallStreetZen

NYSE: RCUS
Arcus Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RCUS

Based on 8 analysts offering 12 month price targets for Arcus Biosciences Inc

Min Forecast
$16.00-23%
Avg Forecast
$30.75+47.98%
Max Forecast
$56.00+169.49%

Should I buy or sell RCUS stock?

Based on 8 analysts offering ratings for Arcus Biosciences Inc.

Buy
Strong Buy
4 analysts 50%
Buy
1 analysts 12.5%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RCUS's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates RCUS as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their RCUS stock forecasts and price targets.

RCUS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-13
lockedlocked$00.00+00.00%2026-01-08
lockedlocked$00.00+00.00%2025-12-12
lockedlocked$00.00+00.00%2025-11-28
lockedlocked$00.00+00.00%2025-10-30
Citigroup
Top 10%
91
Strong BuyMaintains$56.00+169.49%2025-10-29
Wells Fargo
Top 15%
86
Strong BuyMaintains$29.00+39.56%2025-10-20
Truist Securities
Bottom 6%
6
Strong BuyReiterates$39.00+87.68%2025-10-07

1 of 1

Forecast return on equity

Is RCUS forecast to generate an efficient return?

Company
-7.75%
Industry
312.31%
Market
236.81%
RCUS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RCUS forecast to generate an efficient return on assets?

Company
-3.47%
Industry
115.66%
RCUS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RCUS earnings per share forecast

What is RCUS's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
-$4.01
Avg 2 year Forecast
-$3.54
Avg 3 year Forecast
-$2.63

RCUS revenue forecast

What is RCUS's revenue in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$122.7M-48.88%
Avg 2 year Forecast
$147.1M-38.69%
Avg 3 year Forecast
$411.7M+71.55%
RCUS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RCUS revenue growth forecast

How is RCUS forecast to perform vs Biotechnology companies and vs the US market?

Company
14.01%
Industry
118.17%
Market
23.28%
RCUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RCUS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RCUS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RCUS$20.78$30.75+47.98%Buy
GLPG$33.93$36.00+6.10%Buy
WVE$13.59$34.75+155.70%Strong Buy
IMNM$24.93$32.38+29.86%Strong Buy
MESO$17.99N/AN/A
View Top Biotech Stocks

Arcus Biosciences Stock Forecast FAQ

Is Arcus Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NYSE: RCUS) stock is to Buy RCUS stock.

Out of 8 analysts, 4 (50%) are recommending RCUS as a Strong Buy, 1 (12.5%) are recommending RCUS as a Buy, 3 (37.5%) are recommending RCUS as a Hold, 0 (0%) are recommending RCUS as a Sell, and 0 (0%) are recommending RCUS as a Strong Sell.

If you're new to stock investing, here's how to buy Arcus Biosciences stock.

What is RCUS's earnings growth forecast for 2026-2028?

(NYSE: RCUS) Arcus Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.79%.

Arcus Biosciences's earnings in 2026 is -$341,000,000.On average, 13 Wall Street analysts forecast RCUS's earnings for 2026 to be -$433,405,774, with the lowest RCUS earnings forecast at -$512,356,023, and the highest RCUS earnings forecast at -$359,508,685. On average, 12 Wall Street analysts forecast RCUS's earnings for 2027 to be -$381,772,829, with the lowest RCUS earnings forecast at -$430,663,246, and the highest RCUS earnings forecast at -$336,715,472.

In 2028, RCUS is forecast to generate -$283,592,492 in earnings, with the lowest earnings forecast at -$338,605,009 and the highest earnings forecast at -$221,075,815.

What is RCUS's revenue growth forecast for 2026-2028?

(NYSE: RCUS) Arcus Biosciences's forecast annual revenue growth rate of 14.01% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.28%.

Arcus Biosciences's revenue in 2026 is $240,000,000.On average, 13 Wall Street analysts forecast RCUS's revenue for 2026 to be $13,246,193,396, with the lowest RCUS revenue forecast at $740,698,457, and the highest RCUS revenue forecast at $27,317,304,608. On average, 12 Wall Street analysts forecast RCUS's revenue for 2027 to be $15,887,226,087, with the lowest RCUS revenue forecast at $0, and the highest RCUS revenue forecast at $31,982,841,099.

In 2028, RCUS is forecast to generate $44,454,864,242 in revenue, with the lowest revenue forecast at $19,998,858,338 and the highest revenue forecast at $87,723,099,323.

What is RCUS's forecast return on assets (ROA) for 2026-2029?

(NYSE: RCUS) forecast ROA is -3.47%, which is lower than the forecast US Biotechnology industry average of 115.66%.

What is RCUS's Price Target?

According to 8 Wall Street analysts that have issued a 1 year RCUS price target, the average RCUS price target is $30.75, with the highest RCUS stock price forecast at $56.00 and the lowest RCUS stock price forecast at $16.00.

On average, Wall Street analysts predict that Arcus Biosciences's share price could reach $30.75 by Jan 13, 2027. The average Arcus Biosciences stock price prediction forecasts a potential upside of 47.98% from the current RCUS share price of $20.78.

What is RCUS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: RCUS) Arcus Biosciences's current Earnings Per Share (EPS) is -$3.44. On average, analysts forecast that RCUS's EPS will be -$4.01 for 2026, with the lowest EPS forecast at -$4.75, and the highest EPS forecast at -$3.33. On average, analysts forecast that RCUS's EPS will be -$3.54 for 2027, with the lowest EPS forecast at -$3.99, and the highest EPS forecast at -$3.12. In 2028, RCUS's EPS is forecast to hit -$2.63 (min: -$3.14, max: -$2.05).

What is RCUS's forecast return on equity (ROE) for 2026-2029?

(NYSE: RCUS) forecast ROE is -7.75%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.